Iguratimod as an alternative therapy for systemic sclerosis and prevention of the occurrence of ischemic digital ulcer

OBJECTIVES: This study aimed to assess the effectiveness of iguratimod (IGU) as an alternative treatment for systemic sclerosis (SSc), especially in the prevention of ischemic digital ulcers (DUs). METHODS: We constructed two cohorts from the Renji SSc registry. In the first cohort, SSc patients rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Qingran, Liu, Bei, Wang, Jieying, Yin, Hanlin, Li, Qianqian, Lu, Liangjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196471/
https://www.ncbi.nlm.nih.gov/pubmed/37215710
http://dx.doi.org/10.3389/fmed.2023.1113408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196471/
https://www.ncbi.nlm.nih.gov/pubmed/37215710
http://dx.doi.org/10.3389/fmed.2023.1113408

Ejemplares similares